(Q43966065)

28 November 2017

title

Periprocedural myocardial infarction and mortality: causality versus association (English)

1 reference

28 November 2017

main subject

myocardial infarction

1 reference

inferred from title

author name string

Brahmajee K Nallamothu

series ordinal

1

1 reference

28 November 2017

Eric R Bates

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Journal of the American College of Cardiology

28 November 2017

published in

1 reference

28 November 2017

volume

42

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

1412-1414

1 reference

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets: what's behind this new lexicon and what does it add?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Prognostic implication of creatine kinase elevation following elective coronary artery interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Prognostic implication of troponin I elevation after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Myonecrosis after revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Management of patients undergoing percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Beneficial impact of preconditioning during PTCA on creatine kinase release

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

Relation of inflammation and benefit of statins after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901037-4

7 January 2021

10.1016/S0735-1097(03)01037-4

Identifiers

DOI

1 reference

28 November 2017

1 reference